S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

MGRX Mangoceuticals Inc

0.4885

0.0285 (6.20%)

After Hours

Last Updated: 17:24:24

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Mangoceuticals (NASDAQ:MGRX)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Mangoceuticals Charts.

Mangoceuticals (NASDAQ:MGRX)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Mangoceuticals Charts.

Mangoceuticals Inc News

MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts
Thursday 23 May 2024 (10 hours ago) • GlobeNewswire Inc.

MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications
Tuesday 21 May 2024 (2 days ago) • GlobeNewswire Inc.

MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration
Thursday 16 May 2024 (1 week ago) • GlobeNewswire Inc.

Form ARS - Annual Report to Security Holders
Thursday 16 May 2024 (1 week ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Thursday 16 May 2024 (1 week ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 15 May 2024 (1 week ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Tuesday 14 May 2024 (1 week ago) • Edgar (US Regulatory)

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Monday 6 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Monday 6 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement
Thursday 2 May 2024 (3 weeks ago) • GlobeNewswire Inc.

Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive Care
Thursday 25 April 2024 (4 weeks ago) • GlobeNewswire Inc.

Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products
Friday 12 April 2024 (1 month ago) • GlobeNewswire Inc.

More Mangoceuticals Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions